Description: This companion to Braunwald's Heart Disease is written by Dr. Ballantyne and a group of contributing authors that includes the world's leading lipid authorities. This update to the original 2009 publication includes full-text, online access.
Purpose: This book serves as a comprehensive, in-depth resource for physicians interested in the treatment and prevention of atherosclerotic cardiovascular disease. It provides up-to-date information on all currently available treatments for dyslipidemia.
Audience: The audience is cardiologists, endocrinologists, and internists seeking a thorough, comprehensive authority on lipid management. It is an excellent resource for physicians who want information beyond what the current guidelines provide.
Features: This comprehensive book covers everything from the basic science behind lipid metabolism to risk assessment and therapeutic options. Individual chapters cover every clinically used treatment option from the workhorse class of statins to drugs such as bile acid sequestrants, niacin, and omega 3 fatty acids. These chapters are particularly clinically useful as they include specific tables or sections on the current clinical use of these medications.
Assessment: This second edition remains an unparalleled resource for clinicians seeking an authoritative reference on clinical lipid management.